Seanette Wilson | Senior Programme Manager
Biovac Institute
I obtained my PhD in synthetic organic chemistry at the University of Cape Town before starting at The Biovac Institute, a vaccine manufacturing and distribution company based in Cape Town, as a Senior Product Development Scientist. When first starting at Biovac, I was responsible for the development of purification and conjugation processes for a Haemophilus influenza type b (Hib) conjugate vaccine as well as the transfer of these technologies to two international vaccine manufacturers. After managing a pneumococcal conjugate vaccine development project funded by PATH and the development of a multivalent Group b Streptococcus conjugate vaccine, I moved into the Project Management Office. Currently I am a Senior Programme Manager for the development and licensure of an oral cholera vaccine. In addition, I am a member of a Scientific Advisory Board for a CARB-X funded project based at Jenner Institute, University of Oxford and a BactiVac Management Oversight Board Member.
Appearances:
Pre-Congress Workshops - 21st April @ 10:00
ANTIMICROBIAL RESISTANCE
Pre-Congress Workshops - 21st April @ 14:00
DRIVING KOREA’S VACCINE R&D CAPABILITIES TOWARDS REGIONAL AND GLOBAL PUBLIC HEALTH
This workshop will be split into two sections, starting with Korea’s Efforts to Contribute to Regional and Global Vaccine R&D, followed by International Partnerships for Vaccine Equity. Join this workshop to meet speakers not only from South Korea, but also from other international Asian markets that are driving vaccine R&D and manufacturing capacity.
2:00 Korea’s Efforts to Contribute to Regional and Global Vaccine R&D
Current and planned efforts by Korean government and industry to support regional and global Vaccine R&D and local manufacturing
2:45 – 3:30 Panel Discussion with the Korean government and industry on current and future international partnerships in vaccine R&D and local manufacturing
3:30 – 3:45 comfort break
3:45 International Partnerships for Vaccine Equity
Collaboration between Korean and international partners to support regional and global health through partnership in R&D and establishment of local manufacturing of vaccine in LMICs
4:15 Panel: What does it take to collaborate for impact on global vaccine equity? What are some best practices of effort for vaccine R&D and local manufacturing in LMICs?
Main Congress Day 2 - 23rd April @ 12:10
Panel: Strengthening the market and regulatory access of vaccines in Africa
- How do we increase local vaccine manufacturing capacity and bolster regulatory systems within African nations?
- The power of fostering regional collaboration on procurement and market dynamics
- Building capacity for R&D and implementing and strengthening African vaccine manufacturers
- The need for targeted initiatives to address vaccine hesitancy
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events